1. Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Carvalheiro M, Máximo V, Sobrinho-Simões M, Soares P

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas. The Journal of clinical endocrinology and metabolism 99: E754-65, 2014.  [Article] 

 doi: 10.1210/jc.2013-3734 PMID: 24476079.

 

2. Ferreira LB, Tavares C, Pestana A, Pereira CL, Eloy C, Pinto MT, Castro P, Batista R, Rios E, Sobrinho-Simões M, Gimba ER, Soares P

Osteopontin-a splice variant is overexpressed in papillary thyroid carcinoma and modulates invasive behavior. Oncotarget 7: 52003-52016, 2016.  [Article] 

 doi: 10.18632/oncotarget.10468 PMID: 27409830.

 

3. Tavares C, Melo M, Cameselle-Teijeiro JM, Soares P, Sobrinho-Simões M

ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome. European journal of endocrinology 174: R117-26, 2016.  [Review] 

 doi: 10.1530/EJE-15-0605 PMID: 26510840.

 

4. Ferreira LB, Eloy C, Pestana A, Lyra J, Moura M, Prazeres H, Tavares C, Sobrinho-Simões M, Gimba E, Soares P

Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma. European journal of endocrinology 174: 551-61, 2016.  [Article] 

 doi: 10.1530/EJE-15-0577 PMID: 26811408.

 

5. Tavares C, Coelho MJ, Melo M, da Rocha AG, Pestana A, Batista R, Salgado C, Eloy C, Ferreira L, Rios E, Sobrinho-Simões M, Soares P

pmTOR is a marker of aggressiveness in papillary thyroid carcinomas. Surgery 160: 1582-1590, 2016.  [Article] 

 doi: 10.1016/j.surg.2016.06.050 PMID: 27574774.

 

6. Ferreira LB, Lima RT, Bastos ACSDF, Silva AM, Tavares C, Pestana A, Rios E, Eloy C, Sobrinho-Simões M, Gimba ERP, Soares P

OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines. International journal of molecular sciences 19: ., 2018.  [Article] 

 doi: 10.3390/ijms19102990 PMID: 30274371.

 

7. Tavares C, Eloy C, Melo M, Gaspar da Rocha A, Pestana A, Batista R, Bueno Ferreira L, Rios E, Sobrinho Simões M, Soares P

mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression. International journal of molecular sciences 19: ., 2018.  [Article] 

 doi: 10.3390/ijms19051448 PMID: 29757257.

 

8. Santos T, Tavares C, Sousa D, Vaz J, Calhelha R C, Martins A, Almeida G M, Ferreira I, Vasconcelos M H

Suillus luteus methanolic extract inhibits cell growth and proliferation of a colon cancer cell line Food Research International  1, 2013.  [Article] 

 doi: 10.1016/j.foodres.2013.05.037.

 

9. Tavares C, Coelho MJ, Eloy C, Melo M, da Rocha AG, Pestana A, Batista R, Ferreira LB, Rios E, Selmi-Ruby S, Cavadas B, Pereira L, Sobrinho Simões M, Soares P

NIS expression in thyroid tumors, relation with prognosis clinicopathological and molecular features. Endocrine connections 7: 78-90, 2018.  [Article] 

 doi: 10.1530/EC-17-0302 PMID: 29298843.

 

10. Oliveira M, Reis FS, Sousa D, Tavares C, Lima RT, Ferreira IC, Santos TD, Vasconcelos MH

A methanolic extract of Ganoderma lucidum fruiting body inhibits the growth of a gastric cancer cell line and affects cellular autophagy and cell cycle. Food & function 5: 1389-94, 2014.  [Article] 

 doi: 10.1039/c4fo00258j PMID: 24892846.

 

11. Cappagli V, Potes CS, Ferreira LB, Tavares C, Eloy C, Elisei R, Sobrinho-Simões M, Wookey PJ, Soares P

Calcitonin receptor expression in medullary thyroid carcinoma. PeerJ 5: e3778, 2017.  [Article] 

 doi: 10.7717/peerj.3778 PMID: 28929017.

 

12. Tavares C, de Oliveira JT, Lopes C, Carvalheira J, Matos AJ, Rutteman G, Reis CA, Gärtner F

Mucin 6 and tn antigen expression in canine mammary tumours: correlation with pathological features. Journal of comparative pathology 147: 410-8, 2012.  [Article] 

 doi: 10.1016/j.jcpa.2012.03.007 PMID: 22595635.